Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Yishen Wang

Showing results (1-10 of 31) with videos related to

Pageof 4
Sort By:
Health Informatics Journal|August 3, 2018
Selecting antithrombotic therapy for stroke prevention in atrial fibrillation: Health professionals' feedback on a decision support toolYishen Wang, Beata Bajorek
Therapeutic Advances in Drug Safety|August 2, 2014
Safe use of antithrombotics for stroke prevention in atrial fibrillation: consideration of risk assessment tools to support decision-makingYishen Wang, Beata Bajorek
Cardiology Journal|January 11, 2017
Pilot of a Computerised Antithrombotic Risk Assessment Tool Version 2 (CARATV2.0) for stroke prevention in atrial fibrillationYishen Wang, Beata Bajorek
International Journal of Clinical Pharmacy|June 12, 2016
Decision-making around antithrombotics for stroke prevention in atrial fibrillation: the health professionals' viewsYishen Wang, Beata Bajorek
American Journal of Cardiovascular Drugs : Drugs, Devices, and Other Interventions|January 24, 2014
New oral anticoagulants in practice: pharmacological and practical considerationsYishen Wang, Beata Bajorek
Journal of Evaluation in Clinical Practice|June 9, 2016
Clinical pre-test of a computerised antithrombotic risk assessment tool for stroke prevention in atrial fibrillation patients: giving consideration to NOACsYishen Wang, Beata Bajorek
Pharmacy Practice|July 7, 2016
Old age, high risk medication, polypharmacy: a 'trilogy' of risks in older patients with atrial fibrillationYishen Wang, Shamsher Singh, Beata Bajorek
Therapeutic Advances in Drug Safety|February 2, 2018
Contemporary utilization of antithrombotic therapy for stroke prevention in patients with atrial fibrillation: an audit in an Australian hospital settingEkta Yogeshkumar Pandya, Elizabeth Anderson, Clara Chow, et al.
Ophthalmic Research|April 16, 2023
Downregulation of miR-210-3p Attenuates High Glucose-Induced Angiogenesis of Vascular Endothelial Cells via Targeting FGFRL1Tao Wen, Yiwen Hong, Yamei Cui, et al.
Burns : Journal of the International Society for Burn Injuries|October 13, 2015
Recovery of lost face of burn patients, perceived changes, and coping strategies in the rehabilitation stageZhengjia Ren, Weining C Chang, Qin Zhou, et al.
Pageof 4

Showing results (1-10 of 31) with videos related to

Sort By:
Pageof 4
Health Informatics Journal|August 3, 2018
Selecting antithrombotic therapy for stroke prevention in atrial fibrillation: Health professionals' feedback on a decision support toolYishen Wang, Beata Bajorek
Therapeutic Advances in Drug Safety|August 2, 2014
Safe use of antithrombotics for stroke prevention in atrial fibrillation: consideration of risk assessment tools to support decision-makingYishen Wang, Beata Bajorek
Cardiology Journal|January 11, 2017
Pilot of a Computerised Antithrombotic Risk Assessment Tool Version 2 (CARATV2.0) for stroke prevention in atrial fibrillationYishen Wang, Beata Bajorek
International Journal of Clinical Pharmacy|June 12, 2016
Decision-making around antithrombotics for stroke prevention in atrial fibrillation: the health professionals' viewsYishen Wang, Beata Bajorek
American Journal of Cardiovascular Drugs : Drugs, Devices, and Other Interventions|January 24, 2014
New oral anticoagulants in practice: pharmacological and practical considerationsYishen Wang, Beata Bajorek
Journal of Evaluation in Clinical Practice|June 9, 2016
Clinical pre-test of a computerised antithrombotic risk assessment tool for stroke prevention in atrial fibrillation patients: giving consideration to NOACsYishen Wang, Beata Bajorek
Pharmacy Practice|July 7, 2016
Old age, high risk medication, polypharmacy: a 'trilogy' of risks in older patients with atrial fibrillationYishen Wang, Shamsher Singh, Beata Bajorek
Therapeutic Advances in Drug Safety|February 2, 2018
Contemporary utilization of antithrombotic therapy for stroke prevention in patients with atrial fibrillation: an audit in an Australian hospital settingEkta Yogeshkumar Pandya, Elizabeth Anderson, Clara Chow, et al.
Ophthalmic Research|April 16, 2023
Downregulation of miR-210-3p Attenuates High Glucose-Induced Angiogenesis of Vascular Endothelial Cells via Targeting FGFRL1Tao Wen, Yiwen Hong, Yamei Cui, et al.
Burns : Journal of the International Society for Burn Injuries|October 13, 2015
Recovery of lost face of burn patients, perceived changes, and coping strategies in the rehabilitation stageZhengjia Ren, Weining C Chang, Qin Zhou, et al.
Pageof 4